×
Clover Health Investments Total Long Term Liabilities 2020-2024 | CLOV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Clover Health Investments total long term liabilities from 2020 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Quarterly Chart
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$37.2B
Hims & Hers Health (HIMS)
$15B
Tempus AI (TEM)
$13.5B
Inspire Medical Systems (INSP)
$5.3B
IRhythm Technologies (IRTC)
$3.5B
Privia Health (PRVA)
$3.1B
Enovis (ENOV)
$2.5B
Azenta (AZTA)
$2.1B
Schrodinger (SDGR)
$1.9B
Omnicell (OMCL)
$1.9B
Phreesia (PHR)
$1.7B
10x Genomics (TXG)
$1.5B
Butterfly Network (BFLY)
$1B
Talkspace (TALK)
$652M
Fulgent Genetics (FLGT)
$531M
Standard BioTools (LAB)
$517M
TruBridge (TBRG)
$426M
Nyxoah SA (NYXH)
$357M
Health Catalyst (HCAT)
$338M
SOPHiA GENETICS SA (SOPH)
$319M
Pulmonx (LUNG)
$262M
American Well (AMWL)
$191M
EUDA Health Holdings (EUDA)
$102M
MDxHealth SA (MDXH)
$88M
P3 Health Partners (PIII)
$77M
111 (YI)
$69M
CareCloud (CCLD)
$63M
HeartBeam (BEAT)
$58M
Outset Medical (OM)
$50M
Zepp Health (ZEPP)
$45M